Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

4 Stocks Insiders are Buying This Week

Company insiders often have a better perspective of the company’s future performance than outside investors do.  Furthermore, they have an incentive to diversify their investments away from their employer so that negative company-specific events don’t result in a hit to both their income and to their wealth. So when an insider buys a stock, it should be evidence that the company has good times ahead- and statistically this is the case. Insider Monkey tracks SEC filings that report insider transactions so that we can catch significant changes in an insider’s holdings as well as pick up on any patterns that emerge from insider trading activity. Here are four stocks that have seen insider buying recently:

Delta Air Lines, Inc. (NYSE:DAL)

The CFO of Delta Air Lines Inc (NYSE:DAL) purchased 50,000 shares at an average price of $9.34 per share. A number of hedge funds such as Lansdowne Partners also moved more heavily into the stock in the first quarter of the year. Delta Air Lines Inc (NYSE:DAL)’s stock has rallied 35% over the last year but it still trades at an attractive set of value multiples: its trailing P/E is 8 and its forward P/E based on analyst estimates for 2013 is just over 3. The five-year PEG is only 0.1, so the buy side is taking a much, much more negative position on this stock than the sell-side and now the CFO. Read more coverage of the insider purchase at Delta.

Two Board members at Woodward Inc (NASDAQ:WWD), an industrial goods company which provides control and optimization systems to aerospace and energy markets, bought a total of 13,000 shares of the stock. The transaction prices tended to be between $32.75 and $33.00 per share. Insider Monkey likes to see insider buying, but we really like to see multiple insiders buying because it is an even stronger bullish signal. The first three quarters of Woodward Inc (NASDAQ:WWD)’s fiscal year have seen moderate growth, with earnings per share rising by 5% compared to last year, and it trades at 18 times trailing earnings. Take a closer look at the transaction and the company.

The incoming CEO at Logitech International (NASDAQ:LOGI) has his work cut out for him, with the company reporting a 76% increase in its net losses in its most recent quarter compared to the same period in the previous year. Logitech International (NASDAQ:LOGI) is also being hammered by a consumer trend toward touchscreen devices such as smartphones and tablets, which reduces demand for its consumer peripherals, yet the stock trades at a trailing P/E of 29. But the incoming CEO recently purchased 12,000 shares at an average price of $8.24 per share- he had owned 100,000 shares previously, so this is a significant increase- suggesting that he is confident that he can turn around the company.

Quest Diagnostics Inc (NYSE:DGX) saw its President and CEO, Stephen Rusckowski, buy 5,000 shares at an average price of $59.34. Quest Diagnostics Inc (NYSE:DGX) is growing its business nicely, with earnings per share of $2.10 in the first half of 2012 being more than triple what it had earned by the same point in 2011. The medical diagnostics test company trades at fairly low valuation multiples given its strong market position and historical growth- 14 times trailing earnings and 12 times forward earnings. The stock was a favorite of Relational Investors, which owned 4.2 million shares of the company at the end of the first quarter. Rusckowski had previously bought 20,000 shares of Quest Diagnostics in March. Read our discussion of this insider buy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!